Aker BioMarine will release the fourth quarter 2021 results on Thursday 17 February 2022 at 07:00 CET.
At 09:00 CET on the same day, the management will host a webcast to present the results. Following a presentation, there will be a Q&A session where written questions can be submitted to ir@akerbiomarine.com or over the Teams live event.
The webcasted presentation will be in English. To join, please use the link that is available at www.akerbiomarine.com/investor.
A replay of the presentation and Q&A session material will be made available soon after the presentation at the same web address.
For further information, please contact
Carl Christian Bachke, SVP Investor Relations
Mobile: +47 909 808 48
Email: carl.bachke@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange. More information is available at www.akerbiomarine.com.